Search Results for: market

By Kuldip K. Ambastha The Dow Jones had three down and two up days this week. The coronavirus pandemic has continued to wreak havoc all around the world, and the American capital markets were affected. During 1Q2020, the USA’s GDP (gross domestic product) annualized contraction rate was 4.8%. This figure was announced on Wednesday, April …

Continue reading “GDP Contraction, the Fed, and the Dow Jones – Week of April 27 – May 1, 2020”

By Kuldip K. Ambastha The Dow Jones was up and down this week day by day, similar to what has been seen in the past few weeks. Due to the coronavirus pandemic and its related public health concerns around the world, massive changes have been seen in the USA and these changes have been affecting …

Continue reading “Jobs, Unemployment, and the Dow Jones – Week of March 30 – April 3, 2020”

By Kuldip K. Ambastha This past week was a volatile one in the investment markets, worldwide. “May you live in interesting times” was a quote popularized during the global financial crisis (GFC) era. This same quote applies now as well, in terms of the wild roller coaster ride seen for March 16-20. On a daily …

Continue reading “A Wild Roller Coaster Ride – Week of March 16-20, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha Nearly every time I strayed from the herd, I’ve made a lot of money. Wandering away from the action is the way to find the new action. (Jim Rogers; https://www.goodreads.com/quotes/tag/wall-street) I will tell you the secret to getting rich on Wall Street. You try to be greedy …

Continue reading “On Being Contrarian and Astute”

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 24-28, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha Amazon.com, Inc. (AMZN) caught our attention this week due to a massive reported profit figure. Its quarterly profit figure of $3.3 billion for the most recent quarter exceeded its $3.0 billion figure from one year ago. The $87.4 billion sales figure was also impressive and exceeded expectations. …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 27-31, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, January 14, 2020, Pinterest, Inc. (PINS) stock rose by 9.6% for the day because, as per market research firm eMarketer, Pinterest had 82.4 million American users in 2019. With this data point, Pinterest is now the third-largest American social media platform behind Facebook (FB) and …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 13-17, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Friday, January 3, 2020, Tesla, Inc. (TSLA) delivered a gain of 3.0% closing at an all-time high of $443.01 per share due to positive news. Intra-day, the share price reached as high as $454.00 per share. Tesla beat Wall Street estimates for both car production and …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 30, 2019 – January 3, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Karuna Therapeutics Inc. (KRTX), a clinical-stage biopharmaceutical company, was founded in 2009 and is headquartered in Boston, MA. The company is focused on developing innovative therapies for individuals suffering from disabilities, disorders, and pain. Karuna Therapeutics Inc. has announced that its schizophrenia treatment’s Phase 2 clinical trial …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 18-22, 2019”